U.S. Pharma Stock News

Recent interest in MBX Biosciences (MBX) has been driven by progress across its peptide therapy pipeline, including Phase 2 work on MBX 2109. This has coincided with largely positive analyst sentiment and fresh visibility at major healthcare investor conferences. See our latest analysis for MBX Biosciences. At a share price of $38.09, MBX Biosciences has seen mixed near term trading, with a 30 day share price return of a 6.02% decline, while its 90 day share price return of 48.73% and 1 year...

Recent earnings set the tone for Interface stock Interface (TILE) recently released earnings that slightly exceeded Wall Street expectations. Investors responded to steady profitability, cautious growth signals, and margin support from pricing discipline and lower input costs. See our latest analysis for Interface. Interface’s share price has been firming over recent months, with a 30 day share price return of 8.06% and a 90 day share price return of 31.29%. The 1 year total shareholder...

In the past week, Masco Corporation reported its 2025 fourth-quarter and full-year results, showing slightly lower sales and net income year over year, while also recording a US$5 million impairment on other intangible assets. Alongside these results, Masco outlined 2026 guidance, raised its quarterly dividend to US$0.32, completed a sizeable prior buyback, and authorized a new US$2.00 billion repurchase program focused on shareholder returns and selective bolt-on acquisitions in plumbing,...

Why Stryker’s new trauma product launch matters for shareholders Stryker (SYK) is back in focus after launching its T2 Alpha Humerus Nailing System, a new trauma product aimed at complex upper arm fractures, alongside earnings that exceeded market expectations and an optimistic management outlook. Together, the product launch and earnings update give you two angles to think about: how Stryker is trying to deepen its trauma and orthopedics offering, and how current demand trends are feeding...

Event context and recent share performance With no specific news event driving headlines, Gates Industrial (GTES) has still drawn attention after a recent close at $27.97, alongside month and past 3 months returns of 22.9% and 30.8%. See our latest analysis for Gates Industrial. The recent 22.9% 1 month share price return and 30.8% 3 month share price return, against a 1 year total shareholder return of 23.5% and a 3 year total shareholder return near 2x, points to momentum that has...

In early February 2026, Columbia Sportswear Company announced past fourth-quarter and full-year 2025 results showing slightly lower quarterly sales and earnings, issued 2026 guidance calling for modest full-year net sales growth alongside softer first-quarter expectations, confirmed a regular US$0.30 per-share quarterly dividend payable March 20, 2026, and reported additional share repurchases under its long-running buyback program. Together, these updates highlight a company balancing cost...

In February 2026, Hiab announced a dealer agreement with Custom Truck One Source to expand sales and service coverage for HIAB loader cranes across 12 U.S. states and MOFFETT truck mounted forklifts across eight Northeastern states. This arrangement meaningfully broadens Custom Truck’s access to crane and forklift customers in key Western and Northeastern regions, potentially deepening its role as a one-stop specialty equipment partner for infrastructure clients. Next, we’ll examine how this...

Penske Automotive Group recently reported past fourth quarter and full-year 2025 results showing slightly lower sales and earnings year on year, while its board approved a 1.4% increase in the quarterly dividend to US$1.40 per share, marking the 21st consecutive quarterly raise payable on March 5, 2026. Alongside softer new vehicle and commercial truck volumes, the company continued to reshape its portfolio through acquisitions, divestitures, and share buybacks, aiming to support cash...

Jefferies Financial Group stock: recent performance snapshot Jefferies Financial Group (JEF) has been on investors’ radar after a stretch of mixed returns, with the share price down over the past month and year, but higher across the past 3 years and 5 years. See our latest analysis for Jefferies Financial Group. With the latest share price at $53.72, Jefferies’ recent 7 day share price return of an 8.86% decline and 30 day share price return of a 15.33% decline contrast with its 3 year total...

NCR Voyix (VYX) has been drawing attention after its shares closed at $9.49, with recent returns showing mixed momentum over the past week, month, and past 3 months as investors reassess the story. See our latest analysis for NCR Voyix. That recent 1 day share price gain of 1.50% sits against weaker momentum. A 30 day share price return of 11.06% and a 1 year total shareholder return of 22.78% point to pressure on longer term holders. If NCR Voyix’s mixed performance has you looking around...

Webster Financial (WBS) has drawn investor attention after recent trading, with the stock closing at $71.13. With mixed short term returns and stronger longer term figures, many investors are reassessing the bank’s profile. See our latest analysis for Webster Financial. The recent 1 day share price return of 0.49% and 7 day share price return of 2.73% pull back comes after a 30 day share price return of 10.23% and 90 day share price return of 30.49%, alongside a 1 year total shareholder...

Wondering if Electronic Arts at around US$200 a share is still offering fair value or if the easy money has already been made? This article walks through the key numbers so you can judge for yourself. Electronic Arts shares most recently closed at US$200.62, with returns of 0.3% over 7 days, a 1.8% decline over 30 days, a 1.9% decline year to date, 55.8% over 1 year, 82.0% over 3 years and 41.2% over 5 years. Recent headlines have focused on Electronic Arts in the context of broader gaming...

Earnings shift puts Compass Minerals International in focus Compass Minerals International (CMP) is back on investors’ radar after first quarter results showed sales of US$396.1 million and net income of US$18.6 million, compared with a net loss in the same period last year. See our latest analysis for Compass Minerals International. That earnings turnaround has arrived alongside a sharp shift in sentiment, with a 39.72% 90 day share price return at a US$23.99 share price and a 113.62% 1 year...

In early February 2026, Bath & Body Works, Inc. declared a regular quarterly dividend of US$0.20 per share, payable on 6 March 2026 to shareholders of record on 20 February 2026, while also rolling out an expanded Disney Princess Collection with more than 90 new products and member-exclusive early access. This combination of a continued cash return to shareholders and a high-profile Disney collaboration highlights how Bath & Body Works is using partnerships and loyalty perks to reinforce...

Reinhart Partners’ recent decision to lift its Skyward Specialty Insurance Group (SKWD) position to 3.7% of its portfolio has turned fresh attention to the insurer’s growth, capital strength, and new Power Generation offering. See our latest analysis for Skyward Specialty Insurance Group. Recent price action has been mixed, with a 2.9% 7 day share price return set against a 30 day share price decline of 2.7% and a year to date share price fall of 6.9%. The 3 year total shareholder return of...

Investor day puts Broadstone Net Lease (BNL) in focus Broadstone Net Lease (BNL) has moved into the spotlight after its investor day, where management highlighted a healthcare asset simplification plan, an industrial development pipeline, and the completed US$352 million sale of 57 healthcare properties. See our latest analysis for Broadstone Net Lease. Recent momentum has been firm, with a 1 month share price return of 4.97% feeding into a 12.49% year to date share price gain and a 37.00% 1...

Understanding Oruka Therapeutics after recent trading moves Recent trading in Oruka Therapeutics (ORKA) has drawn attention, with the stock closing at US$32.21 and showing mixed short term performance, including a 1 day decline and losses over the past week and month. See our latest analysis for Oruka Therapeutics. While the recent 1 day, 7 day, and 30 day share price returns are slightly negative, the 90 day share price return of 14.1% and 1 year total shareholder return of 188.1% point to...

In early February 2026, BellRing Brands reported first-quarter fiscal 2026 results showing modest sales growth to US$537.3 million but a sharp drop in net income to US$43.7 million, narrowed full-year guidance, fresh share repurchases totaling about US$97 million in late 2025, and the planned retirement of CEO Darcy Davenport by September 30, 2026. At the same time, BellRing became the focus of multiple securities class action filings alleging misleading disclosures about the sources and...

In February 2026, Humana reported fourth-quarter 2025 revenue of US$32,515 million and a net loss of US$796 million, while issuing 2026 GAAP EPS guidance of at least US$8.89 and highlighting ongoing Medicare Advantage and operational pressures. Amid this, Humana advanced its longer-term plans through AI-powered call-center tools with Google Cloud, a new provider agreement with Zynex, and CenterWell’s acquisition of MaxHealth to expand value-based primary care. We’ll now examine how Humana’s...

Madison Square Garden Entertainment (MSGE) just posted second quarter results that caught investor attention, reporting revenue of US$459.94 million and net income of US$92.72 million, along with higher earnings per share from continuing operations. See our latest analysis for Madison Square Garden Entertainment. The latest earnings release and the extended Infosys partnership come on top of a strong run in the shares, with a 90 day share price return of 38.42% and a 1 year total shareholder...

Huntington Ingalls Industries (HII) recently posted fourth quarter results that exceeded Wall Street’s revenue and profit expectations. Management also pointed to broader gains in shipbuilding productivity, along with ongoing cost and scheduling pressures on margins. See our latest analysis for Huntington Ingalls Industries. The earnings beat and recent update on the John F. Kennedy carrier trials have come after a powerful 90 day share price return of 35.20% and a very large 1 year total...

Reliance (RS) is back in focus after Wall Street analysts flagged upbeat expectations for its upcoming quarterly results, pointing to higher earnings, revenue and net sales across carbon steel, alloy, stainless steel and aluminum products. See our latest analysis for Reliance. At a share price of $343.43, Reliance has pulled back over the last week but still carries a 30 day share price return of 5.99% and a 90 day gain of 28.96%. Its 1 year total shareholder return of 17.34% and 5 year total...

Why BILL Holdings is on investors’ radar today BILL Holdings (BILL) has been drawing attention after recent share price moves. The stock last closed at $46.99 and is showing mixed short term and longer term return figures that investors may want to compare. See our latest analysis for BILL Holdings. Recent trading paints a mixed picture, with a 1 day share price return of 1.34% contrasting with a 1 year total shareholder return of 21.45% decline and a 5 year total shareholder return of 74.49%...

AptarGroup, Inc. recently reported its fourth-quarter and full-year 2025 results, showing higher annual sales and net income, while also announcing fresh first-quarter 2026 earnings guidance and confirming recent share repurchases totaling US$402.33 million under its prior authorization. On the same day, the company launched a new share repurchase program of up to US$600 million, signaling continued balance sheet capacity and a willingness to return substantial capital to shareholders...